125 related articles for article (PubMed ID: 24872469)
1. A CD30(-) Transformed Mycosis Fungoides Case Responding Very Well to Systemic Bexarotene and Methotrexate.
Zindanci I; Kavala M; Turkoğlu Z; Can B; Ozturk E; Zemheri E; Akbulak O; Mansuroglu C; Topaloğlu Demir F
Int J Low Extrem Wounds; 2014 Jun; 13(2):127-129. PubMed ID: 24872469
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
3. Response of CD30+ large cell lymphoma of skin to bexarotene.
Keun YK; Woodruff R; Sangueza O
Leuk Lymphoma; 2002 May; 43(5):1153-4. PubMed ID: 12148901
[TBL] [Abstract][Full Text] [Related]
4. Disease characteristics, prognosis, and response to therapy in patients with large-cell transformed mycosis fungoides: A single-center retrospective study.
O'Donnell M; Zaya R; Correia E; Krishnasamy S; Sahu J; Shi W; Cha J; Alpdogan SO; Porcu P; Nikbakht N
J Am Acad Dermatol; 2022 Jun; 86(6):1285-1292. PubMed ID: 34273458
[TBL] [Abstract][Full Text] [Related]
5. Correlations between clinical and pathological features in 17 cases of mycosis fungoides before and after transformation.
Bittencourt AL; Oliveira PD; Carvalho-Andrade A; Araújo I
Int J Dermatol; 2015 Sep; 54(9):e327-31. PubMed ID: 26147565
[TBL] [Abstract][Full Text] [Related]
6. [Long-term efficacy of autologous stem cell transplantation for stage IV mycosis fungoides].
Di Lucca-Chrisment J; Maubec E; Grossin M; Marinho E; Varet B; Maillard H; Crickx B
Ann Dermatol Venereol; 2009 Nov; 136(11):800-5. PubMed ID: 19917433
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
8. The expression of CXCR3 and CD30 in mycosis fungoides.
Nikoo A
Arch Iran Med; 2012 Mar; 15(3):146-50. PubMed ID: 22369302
[TBL] [Abstract][Full Text] [Related]
9. Spatially Resolved Transcriptomes of CD30+-Transformed Mycosis Fungoides and Cutaneous Anaplastic Large-Cell Lymphoma.
Choi ME; Lee MY; Won CH; Chang SE; Lee MW; Lee WJ
J Invest Dermatol; 2024 Feb; 144(2):331-340.e2. PubMed ID: 37544586
[TBL] [Abstract][Full Text] [Related]
10. Transformed mycosis fungoides: clinicopathological features and outcome.
Barberio E; Thomas L; Skowron F; Balme B; Dalle S
Br J Dermatol; 2007 Aug; 157(2):284-9. PubMed ID: 17573879
[TBL] [Abstract][Full Text] [Related]
11. CD30+ Large Cell Transformation of Mycosis Fungoides During Pregnancy.
Naeini FF; Najafian J; Nilforoushzadeh M
Indian J Dermatol; 2013 Mar; 58(2):160. PubMed ID: 23716837
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of CD30 and CD15 accompanied with simultaneous loss of all pan-T-cell antigens in a case of histological transformation of mycosis fungoides with involvement of regional lymph node: an immunophenotypic alteration resembling classical Hodgkin lymphoma.
Reddi DM; Sebastian S; Wang E
Am J Dermatopathol; 2015 Mar; 37(3):249-53. PubMed ID: 23612034
[TBL] [Abstract][Full Text] [Related]
13. Oral mycosis fungoides with CD30
Goggins CA; Gocke MT; Jang S; DeSimone JA
JAAD Case Rep; 2019 Feb; 5(2):180-183. PubMed ID: 30733988
[No Abstract] [Full Text] [Related]
14. Transformation of Sézary syndrome into CD30+ anaplastic large T-cell lymphoma after alemtuzumab therapy with evidence of clonal unity.
Nevet MJ; Zuckerman T; Sahar D; Bergman R
Am J Dermatopathol; 2015 Jan; 37(1):73-7. PubMed ID: 25548993
[TBL] [Abstract][Full Text] [Related]
15. Mycosis fungoides and CD30+ cutaneous T-cell lymphoma simulating pyoderma gangrenosum in a patient with ulcerative colitis.
Salameh F; Barzilai A; Baum S; Trau H
J Dermatol Case Rep; 2009 Aug; 3(2):30-3. PubMed ID: 21886726
[TBL] [Abstract][Full Text] [Related]
16. CD30+ large cell transformation of mycosis fungoides after psoralen plus ultraviolet A photochemotherapy.
Ogino J; Saga K; Kagaya M; Kamada A; Hirosaki K; Kaneko R; Jimbow K
Br J Dermatol; 2007 Jan; 156(1):148-51. PubMed ID: 17199582
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T-cell phenotype in association with large cell transformation of mycosis fungoides.
Hallermann C; Niermann C; Schulze HJ
Eur J Haematol; 2007 Mar; 78(3):260-3. PubMed ID: 17253970
[TBL] [Abstract][Full Text] [Related]
18. Brentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndrome.
Mehra T; Ikenberg K; Moos RM; Benz R; Nair G; Schanz U; Haralambieva E; Hoetzenecker W; Dummer R; French LE; Guenova E; Cozzio A
JAMA Dermatol; 2015 Jan; 151(1):73-7. PubMed ID: 25317818
[TBL] [Abstract][Full Text] [Related]
19. Immediate Response to Brentuximab Vedotin in a Patient with Localized MF-LCT.
Giza A; Miklusiak K; Hałubiec P; Jaworek A; Zimowska-Curyło D; Dyduch G; Sacha T
Case Rep Dermatol; 2023; 15(1):110-116. PubMed ID: 37497303
[TBL] [Abstract][Full Text] [Related]
20. Oral Mycosis Fungoides: Report of 2 Cases and Review of the Literature.
Alexander-Savino C; Boye-Doe A; Bowers E; Beaven A
Case Rep Dermatol; 2023; 15(1):1. PubMed ID: 37497305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
